Category: Cirrhosis

All Podcast Categories
S3-E51.1 - Preview of MAESTRO-NASH Results: a 2,000-Patient Phase 3 Trial

S3-E51.1 – Preview of MAESTRO-NASH Results: a 2,000-Patient Phase 3 Trial

The 2022 AASLD Liver Meeting takes place November 4th-8th in Washington DC in an effort to advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care. Key Opinion Leaders Stephen Harrison, Jörn Schattenberg and patient advocate Jeff McIntyre join Roger Green in a preview of presentations and posters of interest.

S3-E51 - A Preview of the 2022 AASLD Liver Meeting

S3-E51 – A Preview of the 2022 AASLD Liver Meeting

The 2022 AASLD Liver Meeting takes place November 4th-8th in Washington DC in an effort to advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care. Key Opinion Leaders Stephen Harrison, Jörn Schattenberg and patient advocate Jeff McIntyre join Roger Green in a preview of key presentations and posters of interest.

S3-E50.5 - FIB-4 as a Front-Line Tool for Primary Care Triage

S3-E50.5 – FIB-4 as a Front-Line Tool for Primary Care Triage

Roger Green and Louise Campbell are joined by patient advocates Michael Betel, Wayne Eskridge and Robert Mitchell-Thain to discuss patient involvement in putting a dent in Fatty Liver disease. This conversation explores the use of FIB-4 as a front-line tool for primary care. The advocates share their final thoughts on a change they can make in their country in the next 12 months that might extend beyond the country’s borders.

S3-E50.1 - Patient Needs and Inputs for Trial Design

S3-E50.1 – Patient Needs and Inputs for Trial Design

Roger Green and Louise Campbell are joined by patient advocates Michael Betel, Wayne Eskridge and Robert Mitchell-Thain to discuss patient involvement in putting a dent in Fatty Liver. This conversation explores patient needs and inputs for trial design and the extent to which they are considered.

S3-E50 – Focus on Patient Advocacy

Roger Green and Louise Campbell are joined by patient advocates Michael Betel, Wayne Eskridge and Robert Mitchell-Thain to discuss patient involvement in putting a dent in Fatty Liver. The group explores topics ranging from the economics of drug development to the future of digital therapeutics, all centering around the patient perspective.

S3-E49.4 - Delivering Meaningful Liver Test Results to Patients

S3-E49.4 – Delivering Meaningful Liver Test Results to Patients

Roger Green and Louise Campbell are joined by Dr Kathryn Jack, Professors Ian Rowe and William Alazawi to discuss the recent NICE meeting on use of VCTE in primary care settings. In this conversation, the group explores how to create and train on delivering meaningful test results to patients.

S3-E49.3 - Linking Liver Outcomes and Socioeconomic Status

S3-E49.3 – Linking Liver Outcomes and Socioeconomic Status

Roger Green and Louise Campbell are joined by Dr Kathryn Jack, Professors Ian Rowe and William Alazawi to investigate the link between socioeconomic status and liver health outcomes. In this episode, the group discusses the challenges of developing accessible pathways and who will administer FibroScan in a community setting.

S3-E49.1 - NICE on FibroScan for Primary Care

S3-E49.1 – NICE on FibroScan for Primary Care

Roger Green and Louise Campbell are joined by Professor Ian Rowe and Dr Kathryn Jack to discuss the recent NICE meeting on use of VCTE in primary care settings. The group explores the dynamic challenges of utilizing FibroScan and other noninvasive tests (NITs) for best practice in community settings.

Experience Nudge Learning! Interested in a new way of learning?